SCHEMBL11117722

SCHEMBL11117722

O=C(c1ccc(CO)cc1)C(O)c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.69
CES2 O00748 4/20 0.69
CES1 P23141 4/20 0.69
ALDH1A1 P00352 2/20 0.58
KDM4E B2RXH2 1/20 0.58
MAPK1 P28482 1/20 0.48
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TSHR P16473 2/20 0.45
HSD17B10 Q99714 2/20 0.42
MDM2 Q00987 1/20 0.42
HPGD P15428 1/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
LTA4H P09960 1/20 0.40
ALKBH5 Q6P6C2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5821225 0.93 LMNA (0.69) LMNACES2CES1ALDH1A1KDM4E
SCHEMBL1788851 0.84 LMNA (0.67) LMNACES2CES1ALDH1A1KDM4E
SCHEMBL19859915 0.84 LMNA (0.67) LMNACES2CES1ALDH1A1KDM4E
SCHEMBL18096456 0.84 CES2 (0.67) LMNACES2CES1ALDH1A1KDM4E
Benzoin SCHEMBL145 0.82 CES2 (1.00) LMNACES2CES1ALDH1A1KDM4E
Benzoin SCHEMBL901258 0.82 CES2 (1.00) LMNACES2CES1ALDH1A1KDM4E
Benzoin SCHEMBL10665271 0.82 CES2 (1.00) LMNACES2CES1ALDH1A1KDM4E
Benzoin SCHEMBL2025536 0.82 CES2 (1.00) LMNACES2CES1ALDH1A1KDM4E
Benzoin SCHEMBL5833429 0.82 CES2 (1.00) LMNACES2CES1ALDH1A1KDM4E
Benzoin SCHEMBL28120851 0.82 CES2 (1.00) LMNACES2CES1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9802952-B2 Method and apparatus for the synthesis of dihydroartemisinin and artemisinin derivatives Max-Plank-Gesellschaft zur Förderung der Wissenschaften e.v. (DE) 2017-10-31 US disclosed
US-20160145265-A1 METHOD AND APPARATUS FOR THE SYNTHESIS OF DIHYDROARTEMISININ AND ARTEMISININ DERIVATIVES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-05-26 US disclosed
EP-0114341-A2 Dye-containing layer in a photopolymerisable composition, and process for obtaining relief and printing formes BASF Aktiengesellschaft (DE) 1984-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160145265-A1 METHOD AND APPARATUS FOR THE SYNTHESIS OF DIHYDROARTEMISININ AND ARTEMISININ DERIVATIVES ADH1A, DHODH, DHPS LMNA 1756/4885CES2 1696/4885CES1 791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.